These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Monoclonal antibodies which recognize the acidic configuration of the rabies glycoprotein at the surface of the virion can be neutralizing. Raux H; Coulon P; Lafay F; Flamand A Virology; 1995 Jul; 210(2):400-8. PubMed ID: 7542418 [TBL] [Abstract][Full Text] [Related]
3. G glycoprotein amino acid residues required for human monoclonal antibody RAB1 neutralization are conserved in rabies virus street isolates. Wang Y; Rowley KJ; Booth BJ; Sloan SE; Ambrosino DM; Babcock GJ Antiviral Res; 2011 Aug; 91(2):187-94. PubMed ID: 21693135 [TBL] [Abstract][Full Text] [Related]
4. Common and different antigenic properties of the rabies virus glycoprotein of strains SAD-Vnukovo and Pitman-Moore. Máciková I; Dedek L; Vrzal V; Kontseková E; Kontsek P; Ciampor F; Novák M Acta Virol; 1992 Dec; 36(6):541-50. PubMed ID: 1284868 [TBL] [Abstract][Full Text] [Related]
5. Characterization of an antigenic site that contains a dominant, type-specific neutralization determinant on the envelope protein domain III (ED3) of dengue 2 virus. Gromowski GD; Barrett AD Virology; 2007 Sep; 366(2):349-60. PubMed ID: 17719070 [TBL] [Abstract][Full Text] [Related]
6. Further studies on the mechanism of rabies virus neutralization by a viral glycoprotein-specific monoclonal antibody, #1-46-12. Irie T; Kawai A Microbiol Immunol; 2005; 49(8):721-31. PubMed ID: 16113501 [TBL] [Abstract][Full Text] [Related]
8. IgG neutralization of type A influenza viruses and the inhibition of the endosomal fusion stage of the infectious pathway in BHK cells. Outlaw MC; Dimmock NJ Virology; 1993 Aug; 195(2):413-21. PubMed ID: 8337821 [TBL] [Abstract][Full Text] [Related]
9. Generation and characterization of human monoclonal antibodies to G5, a linear neutralization epitope on glycoprotein of rabies virus, by phage display technology. Zhao XL; Yin J; Chen WQ; Jiang M; Yang G; Yang ZH Microbiol Immunol; 2008 Feb; 52(2):89-93. PubMed ID: 18380806 [TBL] [Abstract][Full Text] [Related]
10. Two influenza A virus-specific Fabs neutralize by inhibiting virus attachment to target cells, while neutralization by their IgGs is complex and occurs simultaneously through fusion inhibition and attachment inhibition. Edwards MJ; Dimmock NJ Virology; 2000 Dec; 278(2):423-35. PubMed ID: 11118365 [TBL] [Abstract][Full Text] [Related]
11. Monoclonal antibody mapping of the envelope glycoprotein of the dengue 2 virus, Jamaica. Roehrig JT; Bolin RA; Kelly RG Virology; 1998 Jul; 246(2):317-28. PubMed ID: 9657950 [TBL] [Abstract][Full Text] [Related]
12. Antigenic analysis of Punta Toro virus and identification of protective determinants with monoclonal antibodies. Pifat DY; Osterling MC; Smith JF Virology; 1988 Dec; 167(2):442-50. PubMed ID: 2462308 [TBL] [Abstract][Full Text] [Related]
13. Engineering of a recombinant trivalent single-chain variable fragment antibody directed against rabies virus glycoprotein G with improved neutralizing potency. Turki I; Hammami A; Kharmachi H; Mousli M Mol Immunol; 2014 Feb; 57(2):66-73. PubMed ID: 24091293 [TBL] [Abstract][Full Text] [Related]
14. A human IgG1 (b12) specific for the CD4 binding site of HIV-1 neutralizes by inhibiting the virus fusion entry process, but b12 Fab neutralizes by inhibiting a postfusion event. McInerney TL; McLain L; Armstrong SJ; Dimmock NJ Virology; 1997 Jul; 233(2):313-26. PubMed ID: 9217055 [TBL] [Abstract][Full Text] [Related]
15. The human antibody repertoire specific for rabies virus glycoprotein as selected from immune libraries. Kramer RA; Marissen WE; Goudsmit J; Visser TJ; Clijsters-Van der Horst M; Bakker AQ; de Jong M; Jongeneelen M; Thijsse S; Backus HH; Rice AB; Weldon WC; Rupprecht CE; Dietzschold B; Bakker AB; de Kruif J Eur J Immunol; 2005 Jul; 35(7):2131-45. PubMed ID: 15971273 [TBL] [Abstract][Full Text] [Related]
16. Mapping and characterization of a sequential epitope on the rabies virus glycoprotein which is recognized by a neutralizing monoclonal antibody, RG719. Ni Y; Tominaga Y; Honda Y; Morimoto K; Sakamoto S; Kawai A Microbiol Immunol; 1995; 39(9):693-702. PubMed ID: 8577283 [TBL] [Abstract][Full Text] [Related]
18. Competitive binding of neutralizing monoclonal and polyclonal IgG to the HA of influenza A virions in solution: only one IgG molecule is bound per HA trimer regardless of the specificity of the competitor. Taylor HP; Dimmock NJ Virology; 1994 Nov; 205(1):360-3. PubMed ID: 7975232 [TBL] [Abstract][Full Text] [Related]
19. Hemagglutinin 1-specific immunoglobulin G and Fab molecules mediate postattachment neutralization of influenza A virus by inhibition of an early fusion event. Edwards MJ; Dimmock NJ J Virol; 2001 Nov; 75(21):10208-18. PubMed ID: 11581389 [TBL] [Abstract][Full Text] [Related]
20. Epitopes on the dengue 1 virus envelope protein recognized by neutralizing IgM monoclonal antibodies. Beasley DW; Aaskov JG Virology; 2001 Jan; 279(2):447-58. PubMed ID: 11162801 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]